Building the evidence base for shortened MDR-TB treatment regimens.

I D Rusen, Chen-Yuan Chiang
Author Information
  1. I D Rusen: International Union Against Tuberculosis and Lung Disease Paris, France, Division of Research and Development, Vital Strategies New York, NY, USA, Dalla Lana School of Public Health, University of Toronto Toronto, ON, Canada.
  2. Chen-Yuan Chiang: International Union Against Tuberculosis and Lung Disease Paris, France, Division of Pulmonary Medicine, Department of Internal Medicine Wan Fang Hospital, Taipei Medical University, Division of Pulmonary Medicine, Department of Internal Medicine School of Medicine, College of Medicine Taipei Medical University, Taipei, Taiwan cychiang@theunion.org, Email: irusen@theunion.org.

Abstract

No abstract text available.

MeSH Term

Africa
Antitubercular Agents
Clinical Protocols
Humans
Treatment Outcome
Tuberculosis, Multidrug-Resistant

Chemicals

Antitubercular Agents

Word Cloud

Created with Highcharts 10.0.0BuildingevidencebaseshortenedMDR-TBtreatmentregimens

Similar Articles

Cited By